California Public Employees Retirement System’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-54,400
Closed -$1.01M 2252
2021
Q1
$1.01M Sell
54,400
-6,741
-11% -$138K ﹤0.01% 2493
2020
Q4
$1.08M Sell
61,141
-1,100
-2% -$19.3K ﹤0.01% 2421
2020
Q3
$954K Buy
62,241
+20,147
+48% +$378K ﹤0.01% 2314
2020
Q2
$1.07M Buy
42,094
+32,094
+321% +$670K ﹤0.01% 2185
2020
Q1
$155K Hold
10,000
﹤0.01% 2956
2019
Q4
$111K Buy
+10,000
New +$86.9K ﹤0.01% 3266

Other funds holding KNSA

California Public Employees Retirement System's KNSA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2021, closing a stake of 54,400 shares — an estimated $1.01M sold.

California Public Employees Retirement System first reported a position in KNSA in Q4 2019 and held it in 6 quarters. The position peaked at $1.08M in Q4 2020. 102 funds tracked by Wall St. Rank hold KNSA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Kiniksa Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 54,400 Kiniksa Pharmaceuticals shares in Q2 2021, an estimated $1.01M.
  • California Public Employees Retirement System first reported a position in Kiniksa Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Kiniksa Pharmaceuticals position peaked at $1.08M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.